Increased Regulatory Focus On Supply Chain Integrity Brings Together World Leaders & Drug Industry
-- September 24-26 -- Washington, DC
http://www.iirusa.com/trax/Index.cfm/Link=1/newsection=yes/prioritycode=P0922XVERT2
Amid the FDA's new initiative to more aggressively protect American consumers from counterfeit and adulterated drugs, leading Bio/Pharmaceutical companies, Homeland Security, FDA Product Surety Working Group, WHO, CDC, US Customs, USP, healthcare distributors, security professionals, and legal experts address the Security and Competency of the Drug Supply Chain at The Institute for International Research's September Pharmaceutical Supply Chain Integrity Conference. This event is being held September 24- 26, 2003 at The Fairmont Hotel in Washington, DC.
To view the complete agenda and to register, visit:
http://www.iirusa.com/trax/Index.cfm/Link=1/newsection=yes/prioritycode=P0922XVERT2
According to John Dempsey, Executive Director, Trade Relations & Brand Security for Ortho Biotech Products, LP "Counterfeit drug continues to be an issue of great importance to all manufacturers as it relates to the safety of the customers they serve. It is critical that we pool our resources and knowledge and work together in eradicating counterfeit drug from the marketplace."
*Early registration recommended - Multiple tracks are available to serve the needs of a variety of professions including senior management, regulatory, operations, quality control, trade relations, brand and packaging security, distribution, security, pharmacy and medical professions.
PRE-CONFERENCE FULL DAY SYMPOSIA COVERS:
COLD CHAIN MANAGEMENT - Storage And Shipping Of Temperature-Sensitive Goods
STATUS AND DIRECTION OF THE FDA BAR CODE INITIATIVE - Strategies for Implementation
On the Agenda:
COUNTERFEIT DRUGS IN THE MARKETPLACE: ONE COMPANY'S RESPONSE
John Dempsey, Executive Director, Trade Relations & Brand Security
ORTHO BIOTECH PRODUCTS, LP
COUNTERFEIT DRUGS VIA THE INTERNET: A HOMELAND SECURITY CONCERN
Elizabeth Durant, Executive Director, Trade Compliance and Facilitation,
HOMELAND SECURITY, BUREAU OF US CUSTOMS AND BORDER PROTECTION
DRUG COUNTERFEITING: A WORLD HEALTH ORGANIZATION PERSPECTIVE
Eshetu Wondemagegnehu Quality Assurance and Safety of Medicines, Essential Drugs and Medicines Policy (EDM) , WORLD HEALTH ORGANIZATION
AN FDA PERSPECTIVE ON RISK MANAGEMENT PRINCIPLES AS THEY RELATE SUPPLY CHAIN CONTROL AND THE NEW DRUG PROVISIONS ESTABLISHED IN THE BIOTERRORISM ACT
Benjamin England, (former) Regulatory Counsel to the Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs, FDA , HOGAN AND HARTSON
PHARMATERRORISM: AN ANALYSIS OF TERRORIST THREATS TO AMERICA'S MEDICINE SUPPLY CHAIN, Neil C. Livingstone, PhD, Chairman of the Board and CEO, GLOBALOPTIONS, INC
AN INDUSTRY PERSPECTIVE ON COUNTERFEITING AND ILLEGAL TRADE IN PHARMACEUTICALS
Geoff Power, Director of Packaging Security, GMS Global Quality, GLAXOSMITHKLINE, UK
PRODUCT SURETY REPORT: THE FDA INDUSTRY / AGENCY ANTICOUNTERFEITING WORKING GROUP PROJECT
Myles Culbertson, Physical Science Laboratory (PSL), New Mexico State University, Director, PRODUCT SURETY WORKING GROUP
DIVERSION AND SUPPLY CHAIN SECURITY, Donald E. deKieffer, Lawyer, DEKIEFFER AND HORGAN
TRANSFORMING HEALTHCARE DISTRIBUTION: HDMA'S PRODUCT IDENTIFICATION & TRACKING INITIATIVE, Lisa Clowers, Vice President, Supply Chain Processes & Technology, HDMA
CARGO TRACKING AND THEFT PREVENTION
Barry Brandman, President, Danbee Investigations
CTPAT CUSTOMS TRADE PARTNERSHIP AGAINST TERRORISM
James Carson, US Customs
DRUG REIMPORTATION FROM CANADA: CURRENT CONGRESSIONAL STATUS AND IMPACT ON HEALTHCARE INDUSTRY STAKEHOLDERS, Gracie Marie Turner, President, Galen Institute
Bruce Lehman, President and CEO, International Intellectual Property Institute
ANTI-COUNTERFEITING: AUTHENTICATION AND TRACKING TECHNOLOGIES
Access Technologies/ Pharmacia /Johnson & Johnson /Saint-Alexius Hospital /Drug and Virtual Enterprise Project / UCC / PA Consulting (UK) / HDMA
To download the brochure PDF, please visit:
http://www.iirusa.com/trax/index.cfm/Action=PDF/t=m/prioritycode=P0922XVERT2
Discounts Available: Group discounts are available for as little as 3 people. Contact Aloycia Bellillie at 212-661-3500 x3702 for more information. Or email her, abellillie@iirusa.com
Reach this Audience:
Exhibit and sponsorship opportunities at the Supply Chain Integrity conference offers you an excellent opportunity to showcase your product. To learn more about exhibiting and sponsorship opportunities, call Scott Crabtree at 800-345-8016 x3264; or email him; scrabtree@iirusa.com